Young-Adult viewership soars as HBCU Honors defies trends with major gains; expanded long-form now streaming on HBCU Honors YouTube. WASHINGTON, DC, UNITED STATES, December 31, 2025 /EINPresswire.com/ ...
PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) (the “Company” or “PharmaTher”) today announced that CEO Fabio Chianelli has published ...
Proceeds to Support the Company’s Assessment of Opportunities to Advance BX011 and Ongoing Evaluation of Strategic ...
Written feedback from FDA pre-NDA meeting includes a recommendation to conduct a second Phase 3 trial to generate additional ...
Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...
Continuing its journey of giving throughout 2025 through innovative initiatives aligned with Kuwait Vision 2035 ...
KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...
Sagimet Biosciences Inc. stock rated Strong Buy on promising drug data and pipeline growth in acne and MASH. Click for this SGMT stock update.
Big events such as the World Cup are nearing, and massive infrastructure projects are underway. Toll and fare hikes are ...
We are excited to share this progress which would not have been possible without the study participants and their caregivers, investigators and site staff, and all who have contributed to the ...
Contract Research Organization for the REGAL trial has informed the Company that 72 events have occurred in the trial as of December 26, 2025; SELLAS remains blinded to trial outcomesTiming of the fin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback